Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Asset Utilization Ratio (2016 - 2025)

Cytosorbents (CTSO) has disclosed Asset Utilization Ratio for 13 consecutive years, with 0.79 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio rose 10.42% year-over-year to 0.79, compared with a TTM value of 0.79 through Sep 2025, up 10.42%, and an annual FY2024 reading of 0.71, up 32.55% over the prior year.
  • Asset Utilization Ratio was 0.79 for Q3 2025 at Cytosorbents, up from 0.77 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.79 in Q3 2025 and bottomed at 0.46 in Q3 2021.
  • Average Asset Utilization Ratio over 5 years is 0.61, with a median of 0.59 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio plummeted 39.18% in 2021, then skyrocketed 37.11% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.47 in 2021, then increased by 18.2% to 0.55 in 2022, then soared by 30.42% to 0.72 in 2023, then grew by 6.82% to 0.77 in 2024, then increased by 2.45% to 0.79 in 2025.
  • Business Quant data shows Asset Utilization Ratio for CTSO at 0.79 in Q3 2025, 0.77 in Q4 2024, and 0.71 in Q3 2024.